Skip to main content
Top
Published in: Journal of Thrombosis and Thrombolysis 4/2016

01-11-2016

Reasons for exclusion from intravenous thrombolysis in stroke patients admitted to the Stroke Unit

Authors: Manuel Cappellari, Mariachiara Bosco, Stefano Forlivesi, Giampaolo Tomelleri, Nicola Micheletti, Monica Carletti, Paolo Bovi

Published in: Journal of Thrombosis and Thrombolysis | Issue 4/2016

Login to get access

Abstract

Intravenous (IV) thrombolysis is the treatment in ischemic stroke, but only the minority of patients receive this medication. The primary objective of this study was to explore the reasons associated with the decision not to offer IV thrombolysis to stroke patients admitted to the Stroke Unit (SU). We conducted a retrospective analysis based on data collected from 876 consecutive stroke patients admitted to the SU <12 h of symptoms onset, treated or not with IV thrombolysis at the discretion of the treating neurologist. Of the 876 patients, 449 were thrombolysed and 427 non-thrombolysed. Stroke onset >4.5 h (p = 0.001) and unknown time of onset (or stroke present on awakening) (p = 0.004) were reasons listed in the current SPC of Actilyse reasons for exclusion even they occurred singly, whereas mild deficit (or rapidly improving symptoms) (p < 0.001), extra-cranial conditions with increased risk of bleeding (p = 0.004), and history of SNC diseases (p = 0.001) only when they occurred in combination. Severe pre-stroke disability (p = 0.003) was extra-SPC reason for exclusion even when it occurred singly, whereas early CT hypodensity (p < 0.001) only when it occurred in combination. After stratification for intra-SPC reasons for exclusion, early CT hypodensity was associated with decision not offer IV thrombolysis in patients with mild deficit (p < 0.001), age >80 years (p < 0.001), stroke onset >4.5 h (p = 0.005), and unknown time of onset (p = 0.037), while severe pre-stroke disability (p = 0.025) and admission under non-stroke specialist neurologist assessment (p = 0.018) in patients with age >80 years. There are often unjustified reasons for exclusion from IV thrombolysis in SU.
Appendix
Available only for authorised users
Literature
1.
go back to reference Meretoja A, Putaala J, Tatlisumak T et al (2010) Off-label thrombolysis is not associated with poor outcome in patients with stroke. Stroke 41:1450–1458CrossRefPubMed Meretoja A, Putaala J, Tatlisumak T et al (2010) Off-label thrombolysis is not associated with poor outcome in patients with stroke. Stroke 41:1450–1458CrossRefPubMed
2.
go back to reference Karlinski M, Kobayashi A, Mikulik R, Sanak D, Wahlgren N, Czlonkowska A (2012) Intravenous alteplase in ischemic stroke patients not fully adhering to the current drug license in Central and Eastern Europe. Int J Stroke 7:615–622CrossRefPubMed Karlinski M, Kobayashi A, Mikulik R, Sanak D, Wahlgren N, Czlonkowska A (2012) Intravenous alteplase in ischemic stroke patients not fully adhering to the current drug license in Central and Eastern Europe. Int J Stroke 7:615–622CrossRefPubMed
3.
go back to reference Guillan M, Alonso-Canovas A, Garcia-Caldentey J et al (2012) Off-label intravenous thrombolysis in acute stroke. Eur J Neurol 19:390–394CrossRefPubMed Guillan M, Alonso-Canovas A, Garcia-Caldentey J et al (2012) Off-label intravenous thrombolysis in acute stroke. Eur J Neurol 19:390–394CrossRefPubMed
4.
go back to reference Cappellari M, Moretto G, Micheletti N et al (2014) Off-label thrombolysis versus full adherence to the current European alteplase license: impact on early clinical outcomes after acute ischemic stroke. J Thromb Thrombolysis 37:549–556CrossRefPubMed Cappellari M, Moretto G, Micheletti N et al (2014) Off-label thrombolysis versus full adherence to the current European alteplase license: impact on early clinical outcomes after acute ischemic stroke. J Thromb Thrombolysis 37:549–556CrossRefPubMed
5.
go back to reference Toni D, Mangiafico S, Agostoni E et al (2015) Intravenous thrombolysis and intra-arterial interventions in acute ischemic stroke: Italian Stroke Organisation (ISO)-SPREAD guidelines. Int J Stroke 10:1119–1129CrossRefPubMed Toni D, Mangiafico S, Agostoni E et al (2015) Intravenous thrombolysis and intra-arterial interventions in acute ischemic stroke: Italian Stroke Organisation (ISO)-SPREAD guidelines. Int J Stroke 10:1119–1129CrossRefPubMed
6.
go back to reference Adams HP Jr, Bendixen BH, Kappelle LJ et al (1993) Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 24:35–41CrossRefPubMed Adams HP Jr, Bendixen BH, Kappelle LJ et al (1993) Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 24:35–41CrossRefPubMed
7.
go back to reference Bamford J, Sandercock P, Dennis M, Burn J, Warlow C (1991) Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet 337:1521–1526CrossRefPubMed Bamford J, Sandercock P, Dennis M, Burn J, Warlow C (1991) Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet 337:1521–1526CrossRefPubMed
8.
go back to reference Hoh BL, Chi YY, Waters MF, Mocco J, Barker FG 2nd (2010) Effect of weekend compared with weekday stroke admission on thrombolytic use, in-hospital mortality, discharge disposition, hospital charges, and length of stay in the nationwide inpatient sample database, 2002–2007. Stroke 41:2323–2328CrossRefPubMed Hoh BL, Chi YY, Waters MF, Mocco J, Barker FG 2nd (2010) Effect of weekend compared with weekday stroke admission on thrombolytic use, in-hospital mortality, discharge disposition, hospital charges, and length of stay in the nationwide inpatient sample database, 2002–2007. Stroke 41:2323–2328CrossRefPubMed
9.
go back to reference Ogbu UC, Westert GP, Slobbe LC, Stronks K, Arah OA (2011) A multifaceted look at time of admission and its impact on case-fatality among a cohort of ischaemic stroke patients. J Neurol Neurosurg Psychiatry 82:8–13CrossRefPubMed Ogbu UC, Westert GP, Slobbe LC, Stronks K, Arah OA (2011) A multifaceted look at time of admission and its impact on case-fatality among a cohort of ischaemic stroke patients. J Neurol Neurosurg Psychiatry 82:8–13CrossRefPubMed
10.
Metadata
Title
Reasons for exclusion from intravenous thrombolysis in stroke patients admitted to the Stroke Unit
Authors
Manuel Cappellari
Mariachiara Bosco
Stefano Forlivesi
Giampaolo Tomelleri
Nicola Micheletti
Monica Carletti
Paolo Bovi
Publication date
01-11-2016
Publisher
Springer US
Published in
Journal of Thrombosis and Thrombolysis / Issue 4/2016
Print ISSN: 0929-5305
Electronic ISSN: 1573-742X
DOI
https://doi.org/10.1007/s11239-016-1406-8

Other articles of this Issue 4/2016

Journal of Thrombosis and Thrombolysis 4/2016 Go to the issue